Digestive Disease Institute; Virginia Mason Medical Center

Seattle, Washington 98101

0 studies enrolling now · 4 studies all time

What they study most

Chronic Anal Fissures, Crohn Disease, Hepatitis C Virus

Studies at this site

• Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 — Stopped early
• A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease — Completed
• Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients — Completed
• Efficacy and Safety Study With Diltiazem Hydrochloride Cream to Treat Anal Fissures — Completed